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European bat lyssaviruses types 1 and 2 (EBLV-1 and EBLV-2) are widespread in Europe, although little is
known of their evolutionary history. We undertook a comprehensive sequence analysis to infer the selection
pressures, rates of nucleotide substitution, age of genetic diversity, geographical origin, and population growth
rates of EBLV-1. Our study encompassed data from 12 countries collected over a time span of 35 years and
focused on the glycoprotein (G) and nucleoprotein (N) genes. We show that although the two subtypes of
EBLV-1—EBLV-1a and EBLV-1b—have both grown at a low exponential rate since their introduction into
Europe, they have differing population structures and dispersal patterns. Furthermore, there were strong
constraints against amino acid change in both EBLV-1 and EBLV-2, as reflected in a low ratio of nonsynony-
mous to synonymous substitutions per site, particularly in EBLV-1b. Our inferred rate of nucleotide substi-
tution in EBLV-1, approximately 5  105 substitutions per site per year, was also one of the lowest recorded
for RNA viruses and implied that the current genetic diversity in the virus arose 500 to 750 years ago. We
propose that the slow evolution of EBLVs reflects their distinctive epidemiology in bats, where they occupy a
relatively stable fitness peak.
Lyssaviruses (genus Lyssavirus, family Rhabdoviridae) are
RNA viruses with a single-stranded negative-sense genome
that infect a variety of mammals, causing rabies-like diseases.
Although classical rabies is generally associated with carnivo-
rous mammals, there is also evidence that bats are a major viral
reservoir, a phenomenon particularly well studied in North
America and Europe (2, 29, 33).
Currently, there are seven recognized genotypes of lyssavi-
rus defined on the basis of their genetic similarity (6, 17):
rabies virus (genotype 1), Lagos bat virus (genotype 2), Mokola
virus (genotype 3), Duvenhage virus (DUVV; genotype 4),
European bat lyssavirus type 1 (EBLV-1; genotype 5), Euro-
pean bat lyssavirus type 2 (EBLV-2; genotype 6), and Austra-
lian bat lyssavirus (genotype 7). All of the genotypes except
Mokola virus have bat reservoirs, hinting that lyssaviruses orig-
inated in these mammals (4). Additionally, four new lyssavirus
genotypes that infect bats in central and southeast Asia have
been proposed: Aravan virus (24), Khujand virus (24), Irkut
virus (5), and West Caucasian bat virus (5). Genotype 1 is
responsible for classical rabies in terrestrial mammals through-
out the world and in bats in North and South America, as well
as for most rabies-related human deaths worldwide (39). In
Europe, lyssaviruses isolated from bats belong to EBLV-1 and
EBLV-2 (2).
More than 600 cases of EBLV infection have been reported
throughout Europe, most recently in Scotland (7). EBLV-1
infection has also been reported in a small number of terres-
trial mammals, including five sheep in Denmark (32) and a
stone marten in Germany (28). These animals exhibited clini-
cal signs consistent with rabies and later died or were eutha-
nized. In addition, four human deaths due to EBLV have been
reported (15). The overall rarity of EBLV-associated mortality
in terrestrial animals may be because the cross-species trans-
mission of EBLV from bats to other mammals is infrequent,
because cases go undetected, or because the virulence of
EBLV is low compared to that of genotype 1 lyssavirus. Fur-
thermore, it is possible that bats develop persistent EBLV
infection, manifested as the long-term carriage of viral RNA
without overt disease. In particular, some wild-caught bats
have antibody to EBLV for up to 3 years, and viral RNA has
been detected in the tissues of apparently healthy bats (14, 31,
36, 40), although it is also possible that bats experience an
unapparent acute infection and are subject to continual rein-
fection.
Like other lyssaviruses, the negative-sense EBLV genome
encodes five proteins: the nucleoprotein (N), phosphoprotein
(P), matrix protein (M), glycoprotein (G), and RNA polymer-
ase (L) in the order 3-N-P-M-G-L-5. Evolutionary studies of
lyssaviruses have tended to focus on the N protein, a well-
conserved structural protein, and the G protein, which con-
tains domains responsible for host cell receptor recognition
and membrane fusion and which is the major target for the
host neutralizing-antibody response (3).
Although several molecular epidemiological studies of ge-
notype 1 lyssaviruses have been undertaken, to date there has
been only a single such analysis of EBLV (2). This study, which
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utilized the first 400 bp of the N gene, showed that EBLV-1 can
be subdivided into two distinct lineages or subtypes, designated
EBLV-1a and EBLV-1b. However, nothing is known about the
forces shaping EBLV evolution, particularly compared to ge-
notype 1 lyssaviruses, even though this may provide crucial
insights into the propagation of EBLV in bat populations and
the evolutionary interaction between the virus and its mam-
malian hosts. Previous studies of genotype 1 and 7 lyssaviruses
have shown that these viruses are subject to stronger selective
constraints than many other RNA viruses (18, 21). Whether
these constraints reflect a lack of immune-driven selection
pressure or are due to the adaptation of lyssaviruses to repli-
cate in a broad range of cell types, producing complex fitness
trade-offs, is unknown (21).
Here, we present the first comprehensive evolutionary anal-
ysis of EBLV using a variety of analytical methods employed
on sequence data encompassing the G and N genes, as well as
noncoding gene regions of the viral genome. In particular, we
explored whether the selection pressures and rates of evolu-
tionary change observed in these viruses might reflect the pe-
culiarities of their epidemiology in bats, including the possibil-
ity that they establish persistent infections and have low
virulence.
MATERIALS AND METHODS
Sequence data. Gene sequence data were either newly generated or collected
from GenBank. A total of 65 EBLV isolates were obtained, the details of which
are given in Table 1.2 In addition, two complete N and G sequences from DUVV
were also generated in this study. Three different data sets were then compiled:
(i) 54 G gene sequences (1,575 bp), (ii) 63 N gene sequences (1,350 bp), and (iii)
38 sequences of a concatenated 527-nucleotide (nt) noncoding region combining
regions 234 nt and 294 nt 5 and 3 to the G gene, respectively.
Brains were obtained from naturally infected animals or from suckling mice
after a limited number of passages. RNA extraction and cDNA synthesis were
performed as previously described (34). PCR amplification and sequencing were
performed according to previous protocols (2) with primer sets for the N gene of
N127 (5-ATGTAACACCTCTACAATGG-3; nt 55 to 74), N66CS (3-GTGC
TCCARTTTGCRCACA-5; nt 578 to 596), N512 (5-GTGGCWGAYAGAAT
GGAACA-3; nt 493 to 512), and N8m (3-CAGTCTCYTCNGCCATCTC-5;
nt 1567 to 1586). For the G gene, the primer sets were M220 (5-TGGTGTAT
CAACATGRAYTC-3; nt 2999 to 3028) and GG14 (3-GGACTCAGTATGA
TCCCATTG-5; nt 4383 to 4403) for EBLV-1 and GG14M (3-GGACTCAAT
ATTATACCGTTR-5; nt 4383 to 4403) for EBLV-2; G1530 (5-TGTAAGAC
TCCCAAGAWGG-3; nt 4777 to 6372) and G980 (5-GGGTTCGGAAAGGC
ATACA-3; nt 4231 to 4250) for EBLV-1 and G980M (5-GGGTTCGGAAAG
GCATACA-3; nt 4197 to 4215) for EBLV-2; and G1400 (5-TTGCCCTTCTT
GCCTTAGC-3; nt 4646 to 4664), G1400m (5-GCCTTGATGATATTTATTG
CC-3; nt 4657 to 4676), L2 (3-CAAAGGGGAGTTGAGRTTRTA-5; nt 5520
to 5540), or L4 (3-TGATTGTCTTGTTATTGTTTCT-5; nt 5524 to 5543).
Sequence positions are numbered relative to the rabies virus PV genome. After
the removal of identical sequences, multiple sequence alignments of these data
were generated manually using the SE-AL program (http://evolve.zoo.ox.ac.uk/).
Phylogenetic analysis. We estimated phylogenetic trees for a variety of data
sets, including (i) 63 N gene sequences combining EBLV-1, EBLV-2, and
DUVV; (ii) 54 G gene sequences combining EBLV-1, EBLV-2, and DUVV; (iii)
55 N gene sequences from EBLV-1; (iv) 47 G gene sequences from EBLV-1; (v)
38 concatenated noncoding region sequences from EBLV-1; (vi) 38 concate-
nated G, N, and noncoding sequences from EBLV-1; and (vii) 49 concatenated
G and N gene sequences from EBLV-1. All phylogenetic trees were estimated
using a maximum-likelihood (ML) method under the general time-reversible
(GTR) model of nucleotide substitution, with the rate of each substitution type
estimated from the data and using successive rounds of tree bisection reconnec-
tion branch swapping. The ML base frequencies were also estimated from the
data, as were the proportion of invariable sites (I) and a gamma distribution of
rate variation among sites () with four rate categories. Parameter values are
available from the authors on request. The robustness of each tree was assessed
using a bootstrap resampling method, with all 1,000 replicates estimated using
the neighbor-joining procedure but with the input genetic distances produced
under the ML substitution model. All trees were estimated using the PAUP*
package (38).
Recombination tests. Two approaches were employed to determine whether
recombination had occurred in the evolutionary history of the EBLVs. First, the
N and G gene sequence alignments were split into nonoverlapping fragments of
250 bp. Neighbor-joining trees (incorporating the HKY85- substitution model)
were then estimated for each region. Large-scale phylogenetic movements, in-
dicative of recombination, were assessed using bootstrap resampling. Second,
Sawyer’s run test (GeneConv program) (35) was used to search for gene con-
version events between pairs of sequences (that is, runs of sequence similarity
that conflicted with correct phylogenetic relationships).
Analysis of selection pressures. To determine the selection pressures acting on
the EBLVs, we estimated the numbers of nonsynonymous (dN) and synonymous
(dS) substitutions per site for individual codons and lineages using a maximum-
likelihood method that compares various models of sequence evolution (43). To
assess the selection pressures at individual codons, we compared the M7 and M8
models. M7 assumes that codons take 1 of 10 dN/dS values, each estimated from
the data, although no dN/dS category is allowed to exceed 1.0, so that the model
specifies neutral evolution. In contrast, M8 adds an 11th category of codons at
which dN/dS can exceed 1, thereby allowing positive selection. Consequently,
positive selection is supported if M8 rejects M7 under a likelihood ratio test and
contains a category of codons with dN/dS values of 1. The selected codons can
then be identified using a Bayesian approach. To assess the selection pressures
acting on individual lineages of the EBLV tree, we used a likelihood ratio test to
compare the M0 model, which estimates a single dN/dS value for all branches and
codons, with the “free-ratio” model, which allows a different dN/dS ratio for each
lineage of the EBLV trees. Finally, M0 was also compared with a “two-ratio”
model in which separate dN/dS values are estimated for the internal and external
branches of the EBLV trees. All of these methods were implemented using the
CODEML program of the PAML package (42).
Estimating substitution and population dynamics. Rates of nucleotide sub-
stitution per site were estimated using the Bayesian Markov Chain Monte Carlo
method available in the BEAST package (http://evolve.zoo.ox.ac.uk/). This
method utilizes the differences in branch lengths between viruses sampled at
different time points and explores various models of sequence evolution whose
parameters include tree topology, substitution model, and substitution rate.
Uncertainties in the data are reflected in the 95% high-probability density
(HPD) values and hence account for variation in the molecular clocks among
lineages (13). As before, this analysis utilized the GTR-I- model of nucleotide
substitution with parameters optimized during multiple runs. Three population
dynamics models were compared: constant population size, exponential popula-
tion growth, and logistic population growth. The models were compared with
Akaike’s Information Criterion, with the constant and exponential and the ex-
ponential and logistic models differing by a single parameter and the constant
and logistic models differing by two parameters. Finally, for the best-fit model, we
estimated the rate of population growth (r), expressed as the number of new
infections per individual per year, and also the time taken for the epidemic to
double in size () in years using   ln(2)/r.
Analyses of viral dispersion. The longitude and latitude for each EBLV strain
were determined using the Alexandria Digital Library Gazetteer (http://middle
ware.alexandria.ucsb.edu/client/gaz/adl/index.jsp). The degree of linear associa-
tion between pairwise geographic and genetic distances was evaluated using the
standard Pearson correlation coefficient, with significance determined using
Mantel permutation tests with 10,000 row-column permutations (37) and genetic
distances estimated under the ML model described previously. To determine the
geographical location of the putative common ancestor (PCA) of EBLV-1a and
EBLV-1b in the N and G gene data sets, we first inferred the ancestral sequence
for each data set using a parsimony reconstruction procedure (in PAUP*) on the
ML trees estimated previously. This PCA sequence was then added to the
original data set, and a new ML tree was inferred so that the pairwise distance
of each viral isolate (of known geographical location) from the PCA could be
determined.
Nucleotide sequence accession numbers. The new sequences determined in
this study have been submitted to GenBank and assigned accession numbers
AY863220 to AY863408 (EBLV) and AY996321 to AY996324 (DUVV).
RESULTS
Phylogenetic relationships of EBLV isolates. We obtained
EBLV gene sequences from viruses sampled from 12 Euro-
pean countries over a 35-year period. Using both phylogenetic
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TABLE 1. Isolates of EBLV analyzed in this study
Virus Yr ofisolation City of isolation
a Country of
isolation Bat species Source
GenBank
accession no.b
EBLV-1a
9395 GER 1968 Hamburg Germany E. serotinus A. King AY863348 (N)
AY863296 (G)
AY863273 (G5)
AY863235 (G3)
9396 GER 1985 Rostock Germany E. serotinus A. King AY863349 (N)
AY863297 (G)
AY863269 (G5)
AY863231 (G3)
9398 GER 1970 Stade, Niedersachsen Germany E. serotinus A. King AY863350 (N)
AY863298 (G)
AY863247 (G3)
9399 GER 1982 Bremerhaven Germany E. serotinus A. King AY863351 (N)
AY863299 (G)
AY863287 (G5)
AY863249 (G3)
9436 GER 1986 Stade, Niedersachsen Germany E. serotinus A. King AY863352 (N)
9437 GER 1987 Bremen, Bremen Germany E. serotinus A. King AY863353 (N)
AY863300 (G)
AY863280 (G5)
AY863242 (G3)
9438 GER 1988 Neumunster, Schleswig-Holstein Germany E. serotinus A. King AY863354 (N)
9439 GER 1989 Iberg, Niedersachsen Germany E. serotinus A. King AY863301 (G)
AY863279 (G5)
AY863241 (G3)
9440 GER 1989 Braunschweig, Niedersachsen Germany E. serotinus A. King AY863355 (N)
AY863302 (G)
AY863282 (G5)
AY863244 (G3)
9441 GER 1990 Walsrode, Niedersachsen Germany E. serotinus A. King AY863356 (N)
AY863303 (G)
AY863288 (G5)
AY863250 (G3)
9477 GER 1986 Nienburg, Niedersachsen Germany E. serotinus A. King AY863357 (N)
9481 GER 1990 Lubeck Schleswig-Holstein Germany E. serotinus A. King AY863358 (N)
AY863304 (G)
AY863286 (G5)
AY863248 (G3)
9366 HOL 1992 Goor Netherlands E. serotinus CIDC-Lelystad AY863359 (N)
AY863305 (G)
AY863276 (G5)
AY863238 (G3)
9372 HOL 1992 Valthermond Netherlands E. serotinus CIDC-Lelystad AY863360 (N)
AY863306 (G)
AY863274 (G5)
AY863236 (G3)
9478 HOL 1989 Rolde Netherlands E. serotinus A. King AY863361 (N)
AY863307 (G)
9480 HOL 1987 Bellingwolde Netherlands E. serotinus A. King AY863362 (N)
AY863308 (G)
AY863283 (G5)
AY863245 (G3)
94116 HOL 1989 Jubbega Netherlands E. serotinus A. King AY863363 (N)
AY863309 (G)
AY863284 (G5)
AY863246 (G3)
02017 HOL 2000 Soest Netherlands E. serotinus CIDC-Lelystad AY863364 (N)
02018 HOL 2000 Leiden Netherlands E. serotinus CIDC-Lelystad AY863365 (N)
02020 HOL 1999 Woerden Netherlands E. serotinus CIDC-Lelystad AY863366 (N)
02021 HOL 1998 Leens Netherlands E. serotinus CIDC-Lelystad AY863367 (N)
02022 HOL 1998 Oldeberkoop Netherlands E. serotinus CIDC-Lelystad AY863368 (N)
8615 POL 1985 Gdansk Poland E. serotinus D. Seroka AY863369 (N)
AY863310 (G)
9394 POL 1990 Ketrzyn Poland E. serotinus D. Seroka AY863370 (N)
AY863311 (G)
AY863271 (G5)
AY863233 (G3)
Continued on following page
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TABLE 1—Continued
Virus Yr ofisolation City of isolation
a Country of
isolation Bat species Source
GenBank
accession no.b
96031 POL 1994 Dziekanow Poland E. serotinus D. Seroka AY863312 (G)
9397 RUS 1985 Belgorod Russia Human A. King AY863371 (N)
AY863313 (G)
AY863272 (G5)
AY863234 (G3)
01018 SLO 2001 Presov Slovakia E. serotinus R. Franka AY863382 (N)
AY863323 (G)
AY863295 (G5)
AY863257 (G3)
9443 UKR 1987 Volyn region Ukraine V. murinus A. King AY863372 (N)
AY863314 (G)
AY863263 (G5)
AY863225 (G3)
03002 FRA 2003 Angers, Maine et Loire France E. serotinus Institut Pasteur,
Paris
AY863381 (N)
AY863322 (G)
AY863277 (G5)
AY863239 (G3)
9479 DEN 1987 Horsens Denmark E. serotinus A. King AY863373 (N)
AY863315 (G)
AY863281 (G5)
AY863243 (G3)
94109 DEN 1987 Juelsminde Denmark E. serotinus A. King AY863316 (G)
AY863261 (G5)
AY863223 (G3)
94110 DEN 1987 Christiansfeld Denmark E. serotinus A. King AY863374 (N)
02007 DEN 1993 Århus, East Jutland Denmark E. serotinus L. Rønsholt AY863317 (G)
AY863262 (G5)
AY863224 (G3)
02010 DEN 1995 Arden, Northeast Jutland Denmark E. serotinus L. Rønsholt AY863375 (N)
AY863318 (G)
AY863259 (G5)
AY863221 (G3)
02011 DEN 1997 Jerslev, Zealand Denmark E. serotinus L. Rønsholt AY863376 (N)
AY863319 (G)
AY863260 (G5)
AY863222 (G3)
02012 DEN 1999 Holsted, Southwest Jutland Denmark E. serotinus L. Rønsholt AY863377 (N)
02013 DEN 1999 Nr.Nebel, Southwest Jutland Denmark E. serotinus L. Rønsholt AY863378 (N)
AY863320 (G)
AY863267 (G5)
AY863229 (G3)
02015 DEN 2000 Rødding, South Jutland Denmark E. serotinus L. Rønsholt AY863379 (N)
02016 DEN 2002 Janderup, Southwest Jutland Denmark Sheep L. Rønsholt AY863380 (N)
AY863321 (G)
AY863266 (G5)
AY863228 (G3)
EBLV-1b
9367HOL 1992 Wassenaar Netherlands E. serotinus CIDC-Lelystad AY863383 (N)
AY863335 (G)
AY863275 (G5)
AY863237 (G3)
9376 HOL 1993 Moerkapelle Netherlands E. serotinus CIDC-Lelystad AY863384 (N)
AY863339 (G)
AY863270 (G5)
AY863232 (G3)
9377 HOL 1993 Apeldoorn Netherlands E. serotinus CIDC-Lelystad AY863385 (N)
AY863334 (G)
94113 HOL 1992 Schagen Netherlands E. serotinus A. King AY863386 (N)
AY863336 (G)
AY863289 (G5)
AY863251 (G3)
94115 HOL 1992 Bovenkarspel Netherlands E. serotinus A. King AY863387 (N)
AY863327 (G)
AY863293 (G5)
AY863255 (G3)
Continued on following page
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TABLE 1—Continued
Virus Yr ofisolation City of isolation
a Country of
isolation Bat species Source
GenBank
accession no.b
02019 HOL 1999 Limmen Netherlands E. serotinus CIDC-Lelystad AY863388 (N)
AY863324 (G)
02024 HOL 1997 Bergen Netherlands E. serotinus CIDC-Lelystad AY863389 (N)
AY863338 (G)
AY863258 (G5)
AY863220 (G3)
9483 SPA 1987 Granada Spain E. serotinus Institut Pasteur,
Paris
AY863390 (N)
AY863340 (G)
AY863290 (G5)
AY863252 (G3)
94285 SPA 1994 Granada Spain E. serotinus A. Tellez AY863391 (N)
AY863337 (G)
AY863264 (G5)
AY863226 (G3)
8918 FRA 1989 Briey, Meurthe-et-Moselle France E. serotinus Institut Pasteur,
Paris
AY863392 (N)
AY863341 (G)
8919 FRA 1989 Bainville-sur-Madon, Meurthe
et-Moselle
France E. serotinus J. Barrat AY863393 (N)
AY863342 (G)
AY863278 (G5)
9603 FRA 1995 Bourges France E. serotinus J. Barrat AY863394 (N)
AY863328 (G)
AY863294 (G5)
AY863256 (G3)
9906 FRA 1995 Morlaix Finiste`re France E. serotinus J. Barrat AY863395 (N)
AY863332 (G)
0001 FRA 2000 Premilhat, Allier France E. serotinus J. Barrat AY863396 (N)
AY863326 (G)
AY863292 (G5)
AY863254 (G3)
0002 FRA 2000 Fouesnant, Finiste`re France E. serotinus J. Barrat AY863397 (N)
AY863330 (G)
0003 FRA 2000 Ploune´our-Menez, Finiste`re France E. serotinus J. Barrat AY863398 (N)
AY863331 (G)
0102 FRA 2000 Joinville, Haute-Marne France E. serotinus J. Barrat AY863399 (N)
AY863291 (G5)
AY863253 (G3)
02031 FRA 2001 Vallon en Sully, Allier France E. serotinus J. Barrat AY863400 (N)
AY863329 (G)
02032 FRA 2001 Plonquin Finiste`re France E. serotinus E. Picard AY863401 (N)
AY863325 (G)
AY863268 (G5)
AY863230 (G3)
02033 FRA 2001 Waville, Meurthe-et-Moselle France E. serotinus E. Picard AY863402 (N)
AY863333 (G)
AY863265 (G5)
AY863227 (G3)
EBLV-2a
94112 HOL 1989 Andijk Netherlands M. dasycneme A. King AY863405 (N)
AY863346 (G)
9018 HOL 1987 Wommels Netherlands M. dasycneme CIDC-Lelystad AY863403 (N)
AY863347 (G)
9375 HOL 1993 Roden Netherlands M. dasycneme CIDC-Lelystad AY863404 (N)
AY863344 (G)
EBLV-2b
9007 FIN 1986 Helsinki Finland Human Lumio et al.
(1986)
AY863406 (N)
AY863345 (G)
9337 SWI 1993 Versoix Switzerland M. daubentonii R. Zanoni AY863407 (N)
AY863343 (G)
02053 SWI 2002 NAc Switzerland NA R. Zanoni AY863408 (N)
Duvenhage
94286 SA 1981 NA South Africa Minopterus spp. Van der Merwe AY996324 (N)
AY996322 (G)
86132 SA 1971 NA South Africa Human Meredith AY996323 (N)
AY996321 (G)
a The city closest to where the viral isolate was collected.
b Letters in parentheses indicate the region of the genome from which the sequence came. N, nucleoprotein gene; G, glycoprotein gene; G5, noncoding sequence
5 to the glycoprotein gene; G3, noncoding sequence 3 to the glycoprotein gene.
c NA, information not available.
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and pairwise tests, we found no evidence for recombination in
these data, thereby supporting previous studies that concluded
that recombination was rare in lyssaviruses (11).
A maximum-likelihood phylogenetic tree of 63 complete N
gene sequences is shown in Fig. 1 and has a number of signif-
icant features. In particular, the Duvenhage, EBLV-1, and
EBLV-2 genotypes were each identifiable with 100% bootstrap
values, and there was clear evidence for the existence of two
subtypes of EBLV-1 (EBLV-1a and EBLV-1b), although in
this tree there was only weak bootstrap support for the
EBLV-1b clade. Interestingly, although an EBLV-2a clade was
clearly visible, the EBLV-2b group was not monophyletic in
this tree, with the EBLV-2b strains from Switzerland clearly
related to the EBLV-2a strains from Holland. Unfortunately,
the small sample size of the EBLV-2 data set precludes further
analysis of these viruses. Also notable was the fact that
EBLV-1 and EBLV-2 did not form a monophyletic group, as
EBLV-1 and DUVV were more closely related to each other
than EBLV-1 was to EBLV-2, although this assumes midpoint
rooting. As expected given the lack of recombination, similar
tree topologies were inferred for the G gene and the noncod-
ing sequences and when various data sets were combined (all
trees are available from the authors on request).
Given the composition of our data, we paid most attention
to the phylogenetic relationships within EBLV-1. Trees of the
N and G genes for EBLV-1 are shown in Fig. 2 and 3, respec-
tively. Although these trees were similar in topology, we ob-
served an important difference in branching structure between
EBLV-1a and EBLV-1b in both genes. Specifically, the
EBLV-1a isolates fell into a cluster characterized by little geo-
graphical structure, with the lineages defining the German,
Dutch, and Danish strains mixed on the tree, suggesting a free
movement of strains among these localities. Isolates from east-
ern Europe occupied more basal positions (with the exception
FIG. 1. Maximum-likelihood phylogenetic tree depicting the evolutionary relationships among 63 complete N gene sequences from EBLV-1
and EBLV-2 and two isolates of DUVV. Horizontal branches are drawn to scale, and the numbers at specific nodes indicate the degree of bootstrap
support where it is 90%. The tree is midpoint rooted for purposes of clarity only. The “N” before each isolate name signifies the N gene.
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of two Polish strains on the G gene tree), while the French
isolate 03002FRA was the most divergent lineage of all in both
the N and G genes. In contrast, there was more phylogenetic
and geographic structure in the EBLV-1b clade. In particular,
the Dutch strains form a separate group from the French and
the Spanish strains, and the French strains form a basal group.
Furthermore, internal branches within the EBLV-1b group
were, on average, four times longer than those in EBLV-1a,
indicating that this subtype harbors more genetic diversity. For
example, in the G gene tree, the mean length of internal
branches was 0.004 for EBLV-1a and 0.017 for EBLV-1b.
In a previous phylogenetic analysis, some Spanish isolates of
EBLV-1b formed the most divergent group within the subtype,
which led to the proposal that EBLV-1b originated in Africa
and spread to Europe via Spain (2). To test this hypothesis, we
compared the difference in likelihood when the Spanish
strains, instead of the French strains, were placed as the most
basal group in the ML trees. Using the Shimodaira-Hasegawa
test in PAUP*, we found that these trees, which depict differ-
ent phylogeographic histories for EBLV-1b, were not signifi-
cantly different (P  0.356 for N; P  0.142 for G). Conse-
quently, the possibility of a Spanish origin for EBLV-1b cannot
be refuted based on these data.
Geographic spread of EBLVs. To investigate the pattern of
EBLV dispersal in Europe, we examined the association be-
tween geographic and genetic distances for the combined N, G,
and noncoding data sets. We found a significant positive cor-
relation between geographic and genetic distances for both
EBLV-1a (Mantel test; r  0.69; P  0.0009; n  23) and
EBLV-1b (r  0.71; P  0.0001; n  13). This association is
particularly strong for EBLV-1b; based on the current sample
of sequences, the virus appears to have spread along a north-
south axis in the west of Europe (Fig. 4). Although the point of
origin is difficult to identify, particularly given the uncertainty
in the phylogenetic analysis, it is notable that the French iso-
lates tend to fall deep in the tree and have the shortest dis-
tances to the putative common ancestor.
A more complex phylogeographic picture was seen in
EBLV-1a, although this virus has clearly spread along an east-
west axis in northern Europe (Fig. 4). First, for the Danish,
Dutch, and German strains, the relationship between geo-
graphic and genetic distances was far less pronounced (r 0.3;
P  0.0016; n  18), suggesting that there has been some
spatial mixing, as was also apparent in the phylogenetic anal-
ysis. Second, the probable geographic location of the PCA for
EBLV-1a varied depending on which data set was used in the
analysis. For the three genes combined and for the N gene
only, the PCA was located in Germany. However, for G and N
combined, the PCA was located in Denmark, while for G it was
located on the Dutch-German border.
FIG. 2. Maximum-likelihood phylogenetic tree of 55 N gene se-
quences of EBLV-1. Horizontal branches are drawn to scale, and
nodes with 95% bootstrap support are indicated. The tree is rooted
between EBLV-1a and EBLV-1b. The “N” before each isolate name
signifies the N gene.
FIG. 3. Maximum-likelihood phylogenetic tree of 47 G gene se-
quences of EBLV-1. Horizontal branches are drawn to scale, and
nodes with 95% bootstrap support are indicated. The tree is rooted
between EBLV-1a and EBLV-1b. The “G” before each isolate name
signifies the G gene.
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Rates of population growth in EBLV-1. The best-fit popula-
tion dynamic model for EBLV-1a and EBLV-1b was that of
exponential population growth (Table 2). Moreover, the esti-
mated rates of population growth were both similar and low for
the G and N genes, and we found no clear difference in growth
rates between EBLV-1a and EBLV-1b. For the G gene, the mean
growth rate in EBLV-1a was 0.049 new infections per individual
per year, which gives an average epidemic doubling time of 14
years, which was faster than that observed in EBLV-1b at 0.010/
year (mean doubling time, 69 years). However, for the N gene
the situation was reversed and the growth rate was higher in
EBLV-1b (0.053/year; mean doubling time, 13 years) than in
EBLV-1a (0.038/year; mean doubling time, 18 years). Given
this mixed pattern and the fact that the HPD values overlap
between EBLV-1b and EBLV-1a, we conclude that these two
virus populations have grown at similar and relatively low rates.
Because EBLV-1a and EBLV-1b are phylogenetically distinct
and do not present a single panmictic population, it is inappro-
priate to estimate rates of population growth for a combined
EBLV-1a and EBLV-1b data set.
FIG. 4. Sampling locations of all EBLV-1 strains (G, N, and noncoding region) used in this study. EBLV-1a strains are indicated by closed stars,
while EBLV-1b strains are indicated by open circles.
TABLE 2. ML estimates of evolutionary parameters in EBLV
ML estimate
Value
G Gene N Gene
EBLV-1 EBLV-1a EBLV-1b EBLV-1 EBLV-1a EBLV-1b
Best-fit population model Exponential
growth
Exponential
growth
Exponential
growth
Exponential
growth
Exponential
growth
Exponential
growth
Mean ka 5.10 	 10
5 5.77 	 10
5 7.40 	 10
5 6.11 	 10
5 5.57 	 10
5 2.39 	 10
4
HPD k 3.00 	 10
6,
9.16 	 10
5
2.89 	 10
6,
1.07 	 10
4
1.33 	 10
6,
1.70 	 10
4
1.14 	 10
5,
1.09 	 10
4
9.48 	 10
6,
1.00 	 10
4
4.67 	 10
5,
4.28 	 10
4
Mean age (yr) 739 239 422 494 204 72
HPD age (yr) 159, 1,589 47, 555 52, 1,168 154, 1,029 64, 506 26, 152
Mean growth rateb NAc 0.049 0.010 NA 0.038 0.053
HPD growth rate NA 0.0008, 0.115 
0.005, 0.031 NA 0.004, 0.081 0.002, 0.109
Mean epidemic doubling
time () (yr)
NA 14 69 NA 18 13
a Rate of nucleotide substitution per site per year.
b Number of new infections per individual per year.
c NA, not applicable.
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Rates and dates of EBLV-1 evolution. The mean rates of
nucleotide substitution for EBLV-1 estimated using a Bayesian
Markov Chain Monte Carlo approach were very similar for the
G and N genes at 5.10 	 10
5 and 6.11 	 10
5 substitutions
per site per year, respectively, and with overlapping HPD val-
ues (Table 2). Even accounting for the range of HPD values,
these are among the lowest measurable nucleotide substitution
rates reported for RNA viruses (23). There was no consistent
difference between the substitution rates for EBLV-1a and
EBLV-1b, and in all cases, the HPD values overlapped. The
mean rates for the G gene were 5.77 	 10
5 and 7.40 	 10
5
substitutions/site/year for EBLV-1a and EBLV-1b, while the
equivalent rates for the N gene were 5.57 	 10
5 and 2.39 	
10
4 substitutions/site/year for EBLV-1a and EBLV-1b, re-
spectively.
Given these rates of nucleotide substitution, the most recent
common ancestor of the genetic diversity sampled in EBLV-1
was estimated to have existed approximately 500 to 750 years
ago (Table 2). Estimates of the time of the most recent com-
mon ancestor for EBLV-1a were similar for the N and G
genes; for G, the mean age was 239 years, and for N, the mean
value was 204 years. The values for EBLV-1b were more vari-
able. For the G gene, the value was high compared to that of
EBLV-1a (mean age  422 years), although the HPD was
extremely wide (52 to 1,168 years), making it difficult to infer a
date. For the N gene, the mean estimate was extremely low at
72 years, but the HPD was narrower than for G (26 to 152
years). The genetic diversities observed within EBLV-1a and
EBLV-1b are therefore of roughly the same age.
Selection pressures in EBLV. For both the N and G genes of
EBLV-1 and EBLV-2, we found no evidence for positive se-
lection (dN/dS  1) acting at any codon or lineage (the full
results are available from the authors on request). The mean
dN/dS values (estimated using the M0 model) were low in all
cases, revealing the action of relatively strong selective con-
straints. In EBLV-1, the mean dN/dS value for the G gene,
0.088, was nearly twice that observed in the N gene, 0.049.
Mean dN/dS values for EBLV-2 were slightly higher than for
EBLV-1 at 0.097 and 0.068 for G and N, respectively, but
followed the same pattern. Interestingly, the dN/dS value was
consistently higher in EBLV-1a than in EBLV-1b for both the
N and G genes: 0.065 and 0.034 for N and 0.096 and 0.079 for
G. Finally, a comparison of the ratio of dN/dS in the internal
and external branches of the tree (using the “two-ratio” model)
revealed more nonsynonymous substitutions on the external
branches (tips) of the trees than on the interior branches; the
ratios of dN/dS on the external branches to that on the internal
branches were 4.95 for G and 5.75 for N in EBLV-1.
DISCUSSION
Evolutionary history of EBLV-1. By combining a variety of
data, including taxonomic relationships, virus population dy-
namics, and phylogeography, we are able to reveal some im-
portant aspects of the evolutionary history of EBLV-1 in Eu-
rope. First, our molecular-clock estimates suggest that the
current lineages of EBLV-1 arose some 500 to 750 years ago.
Hence, the current genetic diversity in EBLV-1 has a relatively
recent origin, as observed in some other lyssaviruses (18, 21).
Second, we found that EBLV-1a and EBLV-1b have different
patterns of geographical spread and possibly have different
points of introduction into Europe, although both viruses ex-
hibit relatively low rates of population growth.
Of particular importance was the observation that there was
more population mixing in EBLV-1a than in EBLV-1b. In
EBLV-1a, the phylogenetic homogeneity of isolates across
geographic regions suggests that there is an established viral
traffic among bat populations in northern Europe. This process
cannot be explained by the behavior of Eptesicus serotinus bats,
which are not a migratory species (12) and suffer mortality
from EBLV infection. It is therefore possible that long-dis-
tance transmission is facilitated by migratory bat species that
roost with E. serotinus. The large roost sizes and high densities
of many bat species make them well suited to the sustained
transmission and exchange of RNA viruses (26), as well as a
variety of other pathogens (16). Under these conditions, the
transmission of EBLV is most likely maintained through the
transfer of infectious saliva during licking and biting (16). Al-
though 95% of all EBLV-positive bats submitted for diagnostic
tests are E. serotinus, this could result from ascertainment bias
toward anthropophilic species, those that are not experiencing
a decline in population size, or those that suffer fatal infections.
However, the bat species involved in this presumed viral traffic
in northern Europe are unknown. One migratory bat species
that is widely distributed in northern Europe and which has
been proposed to play a role in EBLV transmission is Pipist-
rellus nathusii, although there is currently no evidence for its
involvement (8, 36).
In contrast, the greater spatial structure in the EBLV-1b
tree indicates that there has been less contact between bat
populations from diverse regions in Europe. In particular, the
Dutch strains form a discrete phylogenetic group, implying that
contact networks between northern and southern Europe are
not well established. This may, in part, be due to a decline in
bat populations, as reported in countries like Germany (1, 27),
for reasons that include human intervention. If roosts in inter-
mediary locations disappear, thereby reducing contact between
bat communities, then viral population subdivision will also be
enhanced. Similarly, there may be an absence of migratory
species able to connect the foci of EBLV-1b in southern Eu-
rope (Spain and southern France) with those in more western
(Brittany) and northern (northern France and The Nether-
lands) locations. As a case in point, Tadarida teniotis and Mi-
niopterus schreibersii, which are present in Mediterranean re-
gions, can fly long distances, and are known to carry EBLV-1
(36), are not encountered in northern and western France.
Our analysis of the place of origin for EBLV-1a and
EBLV-1b was more complex, particularly given the small num-
ber of samples available from southern Europe. In the case of
EBLV-1b, a combination of methods suggested that the sam-
pled lineages most likely arose in France and then spread
northward and southward, although an initial entry into Eu-
rope via Spain and southern France cannot be excluded. The
spread of EBLV-1a was even harder to infer, and we were
unable to locate a consistent place of origin. However, the
observation that the virus occupies an east-west axis across
northern Europe implies that the virus spread in a directed
manner across the region.
Evolutionary processes in EBLV. A key aspect of our work
was the observation that EBLV is subject to strong constraints
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against amino acid change. In particular, the dN/dS values es-
timated for EBLV are relatively low for RNA viruses (41),
even in comparison to the G gene of genotype 1 lyssaviruses in
canids (21). Similarly strong selective constraints have previ-
ously been documented in arthropod-borne RNA viruses, pre-
sumably because of the fitness trade-offs that are inherent
when replicating in cell types as different as those from mam-
mals and insects (41). However, the stronger purifying selec-
tion against the N gene relative to the G gene was expected, as
envelope glycoproteins, which often interact with host cell re-
ceptors and are the main targets of the immune response, show
greater amino acid diversity than nucleocapsid proteins in most
RNA viruses (41).
The constrained evolution of EBLV-1 was even more ap-
parent in our analysis of rates of nucleotide substitution. Spe-
cifically, the substitution rates we estimated for EBLV-1 are
not only among the lowest seen in RNA viruses (19, 23), but
lower than those previously reported for genotype 1 lyssa-
viruses. These estimates range from relatively high rates of 1
	 10
3 substitutions/site/year (19, 22) to lower rates of 3.1 	
10
4 to 5.5 	 10
4 substitutions/site/year (4, 6). The lowest
evolutionary rate thus far recorded for genotype 1 lyssaviruses
was 5.06 	 10
5 substitutions/site/year at nonsynonymous sites
(21). However, as the synonymous rate was an order of mag-
nitude greater, at 4.10 	 10
4 substitutions/site/year, the over-
all substitution rate will be higher than that reported here for
EBLV-1.
There are a variety of plausible explanations for the low
rates of evolutionary change in EBLV-1. First, it is possible
that EBLV-1 replicates slowly in its bat hosts so that few
mutational errors are produced per unit time. Very low levels
of EBLV RNAs have been detected in several tissues (brain,
blood, lung, heart, tongue, and esophagus-larynx-pharynx) and
saliva of apparently healthy bats, suggesting either that there is
a nonproductive infection in these species or that these RNAs
are remnants of an earlier lyssavirus infection (36, 40). Never-
theless, some hosts do develop symptoms and succumb to
disease (40). Why this is so is not known. As such, it seems
premature to conclude that EBLV is characterized by espe-
cially low rates of replication.
A second possibility is that peculiarities of the bat immune
system have altered the selection pressures faced by the
EBLVs, in turn putting a brake on rates of evolutionary
change. Although studies of fruit bats have revealed well-de-
veloped immune systems (30), lower levels of agglutinating,
hemagglutinating, and complement-fixing antibodies are pro-
duced in response to various antigens than in conventional
laboratory animals (20), and the peak of primary antibody
response after antigenic challenge is delayed (9). Additionally,
the activation of T lymphocytes is significantly delayed in bats
compared to mice (10, 30). Despite these differences, a previ-
ous study of genotype 1 lyssaviruses reported similar dN/dS
values in bats and terrestrial vertebrates (21), and as yet there
is no evidence for reduced rates of nucleotide substitution in
rabies viruses isolated from bats (4). This suggests that immune
selection is not especially weak in bats compared to other
mammals, although this clearly needs to be explored in more
detail.
Whatever the explanation for the low rate of evolutionary
change in EBLV-1, our study suggests that the virus has
reached an adaptive peak, so that most amino acid changes
reduce fitness and are therefore removed by purifying selec-
tion. This interpretation is supported by a number of observa-
tions. First, as discussed above, rates of nucleotide substitution,
especially at nonsynonymous sites, were low in EBLV-1. More
striking was that the dN/dS ratios on the internal branches of
the EBLV-1 trees were far lower than the equivalent values
seen on external branches. This means that very few nonsyn-
onymous changes have reached fixation during the evolution-
ary history of EBLV-1, as expected if fitness benefits are dif-
ficult to generate. Hence, the nonsynonymous mutations we
see in EBLV-1 most likely represent transient deleterious and
slightly deleterious amino acid changes that are eventually
removed from the population by purifying selection; this ex-
plains why they fall at the tips of phylogenetic trees. Intrigu-
ingly, unusually low rates of nucleotide substitution have also
been recorded in another rhabdovirus, vesicular stomatitis vi-
rus (19). The fact that vesicular stomatitis virus induces a
persistent infection in its mammalian hosts (25) hints that this
form of virus-host relationship might often be associated with
reduced rates of nucleotide substitution. Finally, although the
population sizes of EBLV in European bats are increasing, the
measured growth rates are very low, suggesting that the virus
exists in a near-equilibrium state in many bat species.
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